Impairment Of fertility Studies in which male and female rats received twice daily subcutaneous doses lixisenatide of 2, 29, or 414 mcg/kg prior to pairing through gestation day 6 did not indicate any adverse effects on male or female fertility in rats up to the highest dose tested, 414 mcg/kg, or approximately 400times the clinical systemic exposure at 20 mcg/day based on mcg/m
9 A synthetic version of exendin-4, called exenatide (brand name Byetta), became the first GLP-1 receptor agonist approved by the FDA on April 28, 2005
These services help individuals understand their insurance benefits, assist in prior authorizations, and explore potential financial assistance programs
Vaginal suppositories are specially made to treat problems in the vaginal area or to be absorbed throughout the body
Be realistic about your budget before starting